The highly anticipated financial results for the third quarter of Thermo Fisher Scientific (NYSE: TMO) are scheduled to be disclosed on Wednesday 23rd October 2024. This important update will be made available before market open, providing investors and market participants with key information regarding the company's financial status.
Financial analysts on Wall Street are predicting that the enterprise is expected to report an estimated per share $5.24 profit for the current quarter. Additionally, the company is anticipated to reveal a total revenue of $10.64 billion during this period.
During the same quarter of the previous year, the company made public its income of $5.69 per share, which were derived from a quarterly revenue of $10.57 billion.
Wall Street analysts have unveiled their forecasts for the company's yearly performance, estimating a total revenue of $42.91 billion. Additionally, they expect the company to reach profit of $21.72 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $5.37 | +4.3% | 10.54 B | -1.4% |
| Q1 2024 | $5.11 | +1.6% | 10.35 B | -3.4% |
| Q4 2023 | $5.67 | +5.0% | 10.89 B | -4.9% |
| Q3 2023 | $5.69 | +12.0% | 10.57 B | -1.0% |
| Q2 2023 | $5.15 | -6.5% | 10.69 B | -2.6% |
| *Growth on year-over-year basis | ||||
TMO has scheduled a conference call on 23rd October 2024 at 08:30 AM eastern time to discuss the third quarter financial results and other related information.
Thermo Fisher Scientific (TMO) closed Monday's regular trading session at $595.37, showing a 1.05 percent decline. During the day, TMO shares traded between $591.82 and $600.58, with a day volume of 914.60 thousand shares.
